This text investigates the escalating global crisis of bacterial resistance to existing antibiotic classes and the scientific challenges inherent in developing new therapeutic agents. The authors, Dan I. Andersson and Diarmaid Hughes, synthesize current clinical data and microbiological research to evaluate how resistance mechanisms evolve and persist. By reviewing the relevant literature, the book provides a comprehensive framework for understanding the intersection of bacterial evolution, clinical practice, and the urgent need for pharmacological innovation.

Experts identify this work as a critical resource for researchers and clinicians navigating the complexities of modern infectious disease management. Readers frequently note the technical density of the prose, which serves as a foundational reference for those studying the intersection of microbiology and public health policy.